Supporting Successful Diabetes Product Launches: Tactics for Educating Payers

Note: Data in this study are segmented to present views for Total Benchmark Class and Diabetes respondents.

Study Overview

Effective payer education of new products - in particular new diabetes therapies - has become paramount in the face of the ever-growing role of the payer and government sectors in the marketplace. Specifically, the cost of diabetes therapies necessitates that payers are not only well educated in the benefits of the therapies but also how the products are different from existing treatments. This Best Practices, LLC study delivers benchmarks around timing of education tactics for payers and identifies the most important edcation activities for payers. Additionally, this study contains qualitative insights from industry executives regarding methods for effectively communicating with payers. Executives can use this research to compare their strategies and tactics with those of leading organizations.

Key Topics

• Summary of Key Insights, Findings and Lessons Learned
• Research Participants, Launch Experience, and Therapeutic Area Demographics
• Post-Approval Early Access Programs: Getting to First Reimbursed Prescription Quickly
• Payer Education Starts Early: Focus on Cost and Outcomes
• Voices From the Field: Best Practices, Lessons Learned & Pitfalls
• Future Trends & Issues

• Timing of Education Activities for Payers and Government Entities
• Top Five Education Activities for Payers and Government Entities
• Mix of Market Education Investment

Methodology

Research was conducted through surveys and interviews. Research participants included 34 executives and managers from 26 leading pharmaceutical, biotech and medical device companies. Diabetes/Cardiovascular research participants included 11 executives and managers at 11 different industry leading companies. Interviewed nine selected participants.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.